ASX - By Stock
|
360 |
Re:
Ann: Market Update
|
|
imback
|
50 |
15K |
6 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
50
|
15K
|
6
|
|
ASX - By Stock
|
360 |
Re:
Ann: Market Update
|
|
imback
|
50 |
15K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
50
|
15K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
7 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
1.0K
|
417K
|
7
|
|
ASX - By Stock
|
DYL |
Re:
THE SQUEEZE IS ON
|
|
imback
|
1.9K |
683K |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1.9K
|
683K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
5.4K |
2.7M |
11 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
5.4K |
2.7M |
4 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
5.4K |
2.7M |
15 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
5.4K |
2.7M |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
623
|
272K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
11 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
623
|
272K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
imback
|
88 |
40K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
40K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.0K
|
417K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
23 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.0K
|
417K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
imback
|
88 |
40K |
25 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
40K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
imback
|
88 |
40K |
11 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
40K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
623
|
272K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
4 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
623
|
272K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
623
|
272K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
4 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
623
|
272K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
20 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
22 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
imback
|
273 |
124K |
9 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
124K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
imback
|
273 |
124K |
9 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
124K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
imback
|
273 |
124K |
22 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
124K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
16 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
623
|
272K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
imback
|
5.4K |
2.7M |
15 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
imback
|
272 |
103K |
15 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
272
|
103K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
15 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
12 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
48 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
48
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
3 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
623
|
272K
|
3
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
imback
|
43K |
21M |
50 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
43K
|
21M
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
15 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
imback
|
623 |
272K |
14 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
623
|
272K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
35 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
imback
|
1.0K |
417K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
417K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
imback
|
226 |
82K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
82K
|
5
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Change in substantial holding
|
|
imback
|
5 |
3.2K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
5
|
3.2K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
imback
|
226 |
82K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
82K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZI Successfully Defends Against Jin Cheng ICC Proceedings
|
|
imback
|
433 |
220K |
19 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
433
|
220K
|
19
|
|
ASX - By Stock
|
360 |
Re:
Ann: Appendix 3Y - R Zuckerberg
|
|
imback
|
4 |
1.5K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
4
|
1.5K
|
2
|
|
ASX - By Stock
|
APX |
Re:
Ann: Withdrawal of Innodata's non-binding indicative proposal
|
|
imback
|
182 |
65K |
10 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
182
|
65K
|
10
|
|
ASX - By Stock
|
APX |
Re:
Ann: Withdrawal of Innodata's non-binding indicative proposal
|
|
imback
|
182 |
65K |
4 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
182
|
65K
|
4
|
|
ASX - By Stock
|
APX |
Re:
Ann: Response to ASX Price Query
|
|
imback
|
279 |
100K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
279
|
100K
|
1
|
|